BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29490159)

  • 1. All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(1):6-22. PubMed ID: 28836905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-Cause Mortality for Life Insurance Applicants with a Family History of Coronary Artery Disease Before 60.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2018 Jan; 47(3):159-171. PubMed ID: 30192720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-Cause Mortality for Life Insurance Applicants with the Presence of Bundle Branch Block.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Zamarripa D; Gill S
    J Insur Med; 2019; 48(1):36-47. PubMed ID: 31219368
    [No Abstract]   [Full Text] [Related]  

  • 5. All-Cause Mortality for Diabetics or Individuals with Hyperglycemia Applying for Life Insurance.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill SJ
    J Insur Med; 2016; 46(1):2-12. PubMed ID: 27562107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Carcinoembryonic Antigen with Mortality in an Insurance Applicant Population.
    Rigatti SJ; Stout R
    J Insur Med; 2019; 48(1):24-35. PubMed ID: 31747325
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
    Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
    J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in mortality of insurance applicants with HIV infection.
    Stout RL; Fulks M; Dolan VF
    J Insur Med; 2012; 43(2):67-75. PubMed ID: 22876410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2014 CRL Build Study of Life Insurance Applicants.
    Fulks M; Dolan VF; Stout RL
    J Insur Med; 2016; 46(1):13-9. PubMed ID: 27562108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [State of health of populations residing in geothermal areas of Tuscany].
    Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
    Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependent decline of relative risks in life insurance medical underwriting.
    Kneepkens RF; Lindeboom R
    J Insur Med; 2014; 44(3):170-83. PubMed ID: 25622389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful external validation of a model to predict other cause mortality in localized prostate cancer.
    Kent M; Penson DF; Albertsen PC; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Ehdaie B; Scardino PT; Vickers AJ
    BMC Med; 2016 Feb; 14():25. PubMed ID: 26860993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proBNP as a predictor of all-cause mortality in a population of insurance applicants.
    Clark M; Kaufman V; Fulks M; Dolan VF; Stout RL
    J Insur Med; 2014; 44(1):7-16. PubMed ID: 25004594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.
    Hoffman RM; Koyama T; Albertsen PC; Barry MJ; Daskivich TJ; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Potosky AL; Penson DF
    J Gen Intern Med; 2015 Jul; 30(7):924-34. PubMed ID: 25678374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum globulin predicts all-cause mortality for life insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP Predicts All-Cause Mortality in a Population of Insurance Applicants, Follow-up Analysis and Further Observations.
    Fulks M; Kaufman V; Clark M; Stout RL
    J Insur Med; 2017; 47(2):107-113. PubMed ID: 29490161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Liver Function Tests with Mortality in an Insurance Applicant Population.
    Rigatti SJ; Stout R
    J Insur Med; 2022 Jul; 49(3):172-182. PubMed ID: 36378891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.